Condition: Fluid Overload · Sponsor: Morten H. Bestle
This study evaluates the benefits and harms of goal directed fluid removal with furosemide versus placebo in critical ill adult patients with fluid overload in the intensive care unit. Half of the patients will receive furosemide and the other half placebo. The treatment will continue until the excess fluid is excreted.
This description comes directly from the study's public registry record.
Sine Wichmann, MD · +45 26142620 · sine.wichmann@regionh.dk
Morten Bestle, MD · +45 41951195 · morten.bestle@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Intensive Care, Liverpool Hospital | Sydney, Australia | Recruiting |
| Department of Intensive Care, Royal North Shore Hospital | Sydney, Australia | Recruiting |
| Department of Intensive Care, University Hospital of Ostrava | Ostrava, Czechia | Not Yet Recruiting |
| Department of Intensive Care, University Hospital of Pilsen | Pilsen, Czechia | Recruiting |
| Department of Intensive Care, IKEM | Prague, Czechia | Recruiting |
| Department of Intensive Care, Sygehus Sønderjylland Aabenraa | Aabenraa, Denmark | Terminated |
| Departmen of Intensive Care | Aalborg, Denmark | Recruiting |
| Department of Intensive Care, Aarhus University Hospital | Aarhus, Denmark | Terminated |
| Department of Intensive Care, Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Departement of Intensive Care, Gentofte Hospital | Gentofte Municipality, Denmark | Terminated |
| Department of Intensive Care, Herlev Hospital | Herlev, Denmark | Recruiting |
| Department of Intensive Care, Regionshospital Gødstrup | Herning, Denmark | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04180397